2025-2026 Regular Session • US Congress Legislature
SB1302: Increasing Transparency in Generic Drug Applications Act
Legislative Summary
A bill to provide for increased transparency in generic drug applications.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/3/2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
Status Information
Current Status
Introduced(4/3/2025)
Chamber
Senate
Committee
Health, Education, Labor, And Pensions(Senate)
Sponsors
Democrat: 2
Republican: 2
Primary Sponsor
Margaret Hassan
Democrat